FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Doxycycline Hyclate Injection
Status: Currently in Shortage
»Date first posted: 07/10/2020
»Therapeutic Categories: Anti-Infective

Expand all

Fresenius Kabi USA, LLC (Revised 10/08/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per vial; amber vial; preservative free; lyophilized powder (NDC 63323-130-11) Backordered. Next release expected October 2020. Check wholesalers for inventory Demand increase for the drug

Mylan Institutional (Reverified 10/14/2020)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg (Lyophilizate in Vials)(NDC 67457-437-10) Intermittent supply due to increased demand. Increased supply in July and through remainder of the year to meet demand. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English